Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Preparation method of tumor targeted photothermal therapy nanocarrier and application

A photothermal therapy and tumor targeting technology, which is applied in the field of preparation of nanocarriers for tumor-targeted photothermal therapy, can solve the problems of normal cell damage, patient trauma and complications, and achieves good photothermal therapy effect and good photothermal therapy. Transfer characteristics, mild effects

Active Publication Date: 2017-11-24
BEIJING UNIV OF CHEM TECH
View PDF2 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These methods all have great risks, which are likely to bring great trauma and complications to patients, and at the same time, they are likely to cause great damage to normal cells while killing cancer cells.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of tumor targeted photothermal therapy nanocarrier and application
  • Preparation method of tumor targeted photothermal therapy nanocarrier and application
  • Preparation method of tumor targeted photothermal therapy nanocarrier and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] A method for preparing a tumor-targeted photothermal therapy nanocarrier, comprising the following steps:

[0041] S1. Preparation of GO-MoS 2 Composite: get ammonium molybdate 0.265g, sodium sulfide 1.152g, dissolve in 25ml water respectively, obtain ammonium molybdate and sodium sulfide solution; get 2.5ml (mass concentration is 1%) graphene oxide sol, dilute to 100ml, GO solution was obtained; the ammonium molybdate solution was added to the GO solution, magnetically stirred for 30 minutes, then the sodium sulfide solution was slowly added, and 10ml of 5mol / L hydrochloric acid was added dropwise, and the reaction was carried out for 1 hour;

[0042] S2. Then add 2 g of L-cysteine ​​to the reaction solution, adjust the pH to 4.5, put it into a hydrothermal kettle and react at 200° C. for 24 hours;

[0043] S3, after the reaction solution is cooled, centrifuge and wash at 3500 rpm for 5 min (repeat 6 times), discard the supernatant; obtain sample A;

[0044] S4. Modi...

Embodiment 2

[0049] Repeat Example 1, the only difference is: in the preparation of GO-MoS 2 In the compound process, adjust the addition of sodium sulfide to 0.58g or 2.30g, and the rest of the steps are the same as in Example 1, and MoS can be obtained 2 Samples with different loading ratios.

Embodiment 3

[0051] Repeat Example 1, the only difference is: in the preparation of GO-MoS 2 In the composite process, the graphene oxide powder obtained by the modified Hammers method is used instead of the graphene oxide sol, and the rest of the steps are the same as in Example 1, and GO-MoS can also be prepared 2 The complex can be used to compare the effect of different raw materials on the cytotoxicity of the vector.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of a tumor targeted photothermal therapy nanocarrier. The method comprises steps as follows: with GO as a carrier, loading MoS2 on GO with a hydrothermal method, and performing PEG modification to obtain the GO-MoS2 composite carrier. A composite of GO and MoS2 is taken as a phototherapeutic drug carrier for the first time, the preparation method is simple and convenient, and conditions are mild; the prepared GO-MoS2 drug-carrying composite has good photothermal conversion characteristic and higher drug carrying ratio which is higher than or equal to 80%. The drug release rate of the GO-MoS2 drug-carrying composite is 78% under laser power of 1.8 W / cm<2> in the presence of NIR laser. Compared with a conventional photothermal therapy nano-drug carrier, the GO-MoS2 drug-carrying composite has higher photo-thermal conversion rate due to synergistic effect of the two materials.

Description

technical field [0001] The invention belongs to the technical field of nanomaterials, and in particular relates to a preparation method and application of a tumor-targeted photothermal therapy nanocarrier. Background technique [0002] As a major disease that threatens human life and health, cancer has long been characterized by low cure rate, high recurrence and high mortality. From the statistical point of view, from 2010 to 2015, the number of new cancer cases in my country has shown a clear upward trend, with about 300,000 new cases every year, and the number of deaths has also increased year by year. In 2015, it was 2.814 million cases. . The global cancer incidence has also been on the rise since 2008. In 2012, the number of cases was 14 million, and the number of cases is expected to reach 24 million in 2035. And in recent years, due to people's high life pressure, irregular work and rest diet, and more opportunities to be exposed to carcinogenic factors, new cancer ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K41/00A61K31/704A61K47/60A61K47/04A61K47/02A61P35/00
CPCA61K31/704A61K41/0052A61K47/02A61K2300/00
Inventor 乐园林谡轩陈鹏沈煜栋
Owner BEIJING UNIV OF CHEM TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products